Boston Scientific To Participate In Wells Fargo 2014 Healthcare Conference

PR Newswire

NATICK, Mass., June 3, 2014 /PRNewswire/ -- Boston Scientific Corporation (BSX) is scheduled to participate in the Wells Fargo 2014 Healthcare Conference on June 17 in Boston, MA.

Dan Brennan, executive vice president and chief financial officer, and Susan Lisa, vice president, Investor Relations, will participate in a 30-minute question and answer session regarding the company beginning at approximately 8:50 a.m. ET.

A live webcast of the question and answer session will be available to interested parties via the Boston Scientific website.  Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors.  Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.

This webcast is being hosted by Wells Fargo.  A replay will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the question and answer session.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS
Media:                                                                     
Denise Kaigler                                                          
508-650-8330 (office)                                              
Corporate Affairs & Communications                     
Boston Scientific Corporation                                  
denise.kaigler@bsci.com                                          

Investors:
Susie Lisa, CFA
508- 652-5345 (office)
Investor Relations
Boston Scientific Corporation
investor_relations@bsci.com

Rates

View Comments (0)